Nexus Surgical and Medicare Ltd Financials
Company Logo

Nexus Surgical and Medicare Ltd Financial Statement

Nexus Surgical and Medicare Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Jun 2025
Revenue1.73
Operating Expense1.52
Net Profit0.15
Net Profit Margin8.67
Earning Per Share0.28
EBIDTA0.20
Effective Tax Rate25.00

Nexus Surgical and Medicare Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Total Revenue Annual5.72
Operating Expenses Annual5.06
Operating Profit Annual0.67
Interest AnnualTBA
Depreciation0.00
Net Profit Annual0.50
Tax Annual0.17

Nexus Surgical and Medicare Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Cash Flow at the Beginning0.23
Cash Flow from Operations0.10
Cash Flow from Investing-0.01
Cash Flow from FinancingTBA
Cash Flow at the End0.33

Nexus Surgical and Medicare Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
PBDIT Margin (%)11.89
PBIT Margin (%)11.89
PBT Margin (%)-1,176.92
Net PROFIT Margin (%)8.74
Return On Networth / Equity (%)9.14
Return On Networth /Employed (%)12.43
Return On Assets (%)61.36
Total Debt / Equity (X)TBA
Asset Turnover Ratio (%)7.02

Nexus Surgical and Medicare Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Fixed Assets Annual0.02
Total Current Assets Annual2.24
Non Current Assets Annual0.03
Total Shareholders Funds Annual1.06
Total Assets Annual2.27

Nexus Surgical and Medicare Ltd Earning Calls

No Data Availabe

FAQS on Nexus Surgical and Medicare Ltd Financials

As of Oct 3, 2025, Nexus Surgical and Medicare Ltd has a market capitalization of 9.02 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Nexus Surgical and Medicare Ltd is with a debt-to-equity ratio of 0.00.

In FY 2024 , Nexus Surgical and Medicare Ltd recorded a total revenue of approximately 5.72 Cr marking a significant milestone in the company's financial performance.

Nexus Surgical and Medicare Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.3% and 0.7% annually, respectively..

Nexus Surgical and Medicare Ltd's current PE ratio is 18.04.

Nexus Surgical and Medicare Ltd's ROCE averaged 59.7% from the FY ending March 2023 to 2025, with a median of 62.8%. It peaked at 64.8% in March 2023, reflecting strong capital efficiency over the period..

Nexus Surgical and Medicare Ltd's latest EBIT is Rs. 0.67 Cr, surpassing the average EBIT of Rs. 0.40 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions